Home : FDA Drug Database : Abacavir : News Articles

Abacavir - News Articles

Shionogi-ViiV Healthcare comienzan el ensayo clínico de un nuevo tratamiento para el VIH. europapress.es


combinación de inhibidores de la transcriptasa inversa análogos de nucleósidos de ViiV Healthcare, denominada 'Kivexa' (abacavir/lamivudina -ABC/3TC-). ...
AIDSmeds - Top Stories : U.S. Government Updates HIV Treatment Guidelines


The guidelines panel also added recommendations for Selzentry combined with either Truvada (tenofovir plus emtricitabine) or Epzicom (abacavir plus lamivudine), placing these combinations in the category of “may be acceptable, but more data needed.” As a result of ...
Lifescience-online: your Nr1 resource for pharma and biotech business


KIVEXA/EPZICOM (abacavir/lamivudine) is a once-a-day HIV medication that combines abacavir sulfate and lamivudine in a single tablet and is indicated for ...
Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir


Abacavir has been associated with an increased risk of acute myocardial infarction, but the pathogenic mechanisms remain unknown. We evaluated longitudinal changes in pro-atherosclerotic biomarkers in patients initiating abacavir or tenofovir. Methods: Consecutive patients initiating antiretroviral therapy ...
Alerta VIH - Vida - EL UNIVERSAL


en la entrega del medicamento "Kivexa" -combinación abacavir (Ziagen®), con lamivudina (Epivir®)-, del abacavir en su forma genérica y del tenofovir. ...
Research can be our richest resource: genetic discoveries | The Australian


Our group, for instance, discovered a genetic test for a life-threatening sensitivity to an important anti-HIV drug, abacavir. We were privileged to lead an international effort involving thousands of patients and collaborators that will bring the test to routine use in clinics worldwide ...
News - Switching Antiretroviral Regimens Can Benefit Patients' Lipid Profiles: Presented at ICAAC


"Hence the tenofovir, emtricitabine, efavirenz combination is preferential to an abacavir-based regimen in hypercholesterolemic patients. " Dr. Moyle also noted that while both regimens are given once daily, patients found the single pill more convenient ...
Medical News: ICAAC: Switch to HIV Combo Pill May Improve Lipids - in Meeting Coverage, ICAAC from MedPage Today


Clinicians should note that in patients with hypercholesterolemia on abacavir/lamivudine, the switch to tenofovir/emtricitabine produces moderate improvement in lipid parameters. BOSTON -- Switching therapies may benefit HIV patients with hypercholesterolemia, a researcher said here. Patients ...
AIDSmeds - Top Stories : Switch From Abacavir to Tenofovir Improves Cholesterol Levels


People on a regimen containing abacavir saw their cholesterol drop quickly and significantly when they switched to a similar regimen containing tenofovir. What’s more, people who switched expressed greater satisfaction with their new regimen, said the authors of a study presented ...
Transcriptome analysis of monocyte-HIV interactions - 7thSpace Interactive


Additionally, several candidate biomarkers (in particular CCL1 and CYP2C19) for the development of the abacavir hypersensitivity reaction were suggested. Conclusions: Previously described areas of monocyte dysfunction during HIV infection were confirmed, and novel themes were identified. Furthermore, ...
ART administered during breast-feeding may reduce mother-to-child transmission


There were 285 participants randomly assigned coformulated abacavir, zidovudine and lamivudine (NRTI group) and 275 women assigned lopinavir-ritonavir plus ...
VIH/sida : GSK et Pfizer souhaitent commercialiser une molécule par an dès 2013 MyPharma Editions | L'Info Industrie & Politique de Santé


ViiV Healthcare a actuellement 10 médicaments disponibles dont Kivexa® (abacavir + lamivudine) et Celsentri® (maraviroc). Les revenus provenant de ces médicaments, qui ont généré un chiffre d’affaires d’approximativement 1,6 milliard de livres sterling en 2008, visent à donner à ...
Remédio para paciente com aids está em falta - Vida - Estadao.com.br


O abacavir, medicamento usado por cerca de 3,7 mil pacientes com aids, está em falta no Brasil. O problema teve início em dezembro, quando o Departamento de DST/Aids e Hepatites Virais informou ter havido dificuldade na aquisição do remédio. Naquela época, o programa aconselhou que médicos ...
Principais notícias do dia 7 de abril


De acordo com reportagem do Estadão, a ausência do Abacavir nos hospitais e farmácias teve início em dezembro, quando o Departamento de DST/Aids e Hepatites Virais informou ter havido dificuldade na aquisição do remédio. Para a diretora do Departamento de DST/Aids, Mariangela ...
Remédio para paciente com aids está em falta no País - Vida & - Estadao.com.br

Agência de Notícias da Aids
O abacavir, medicamento usado por cerca de 3,7 mil pacientes com aids, está em falta no Brasil. O problema teve início em dezembro, quando o Departamento de DST/Aids e Hepatites Virais informou ter havido dificuldade na aquisição do medicamento. Naquela época, o programa aconselhou que médicos ...
Want to contact a Washington, DC Abacavir attorney? ...Get a free case evaluation from one of our Washington, DC Abacavir attorneys now.

Need An Abacavir Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact a Washington, DC Abacavir attorney? ...Get a free case evaluation from one of our Washington, DC Abacavir attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Abacavir Case - Submit Your Information Below

Do you need legal assistance with your Abacavir case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * FDA Drug Database: Abacavir Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.